InsiderTrades

Form 4 for HIMS Hims & Hers Health, Inc.

Accepted 2024-12-30 00:00:00 ET · period of report 2024-12-27 · accession 0001773751-24-000413 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-12-30 2024-12-27 HIMS Baird Melissa COO M - OptEx $4.56 +31.5K 701.4K +5% +$143.7K
DM 2024-12-30 2024-12-27 HIMS Baird Melissa COO M - OptEx $0.00 -31.5K 737.9K -4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-12-27 M A 5,518 $2.43 706,872 D — —
2 Common Class A Common Stock 2024-12-27 M A 26,000 $5.01 701,354 D — —
3 Derivative Stock Option (right to buy) 2024-12-27 M D 26,000 $0.00 1,635,128 D $5.01 · — to 2032-02-23 26,000 Class A Common Stock (F1) The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting on March 24, 2022 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.
4 Derivative Stock Option (right to buy) 2024-12-27 M D 5,518 $0.00 737,894 D $2.43 · — to 2030-05-13 5,518 Class A Common Stock (F2) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.